跳至主要内容
临床试验/NCT02233933
NCT02233933Unknown不适用

Randomized Trial of Argon Plasma Coagulation Versus Argon Plasma Coagulation and Hemospray in the Therapy of Radiation Proctitis

British Columbia Cancer Agency1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2014年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
20
试验地点
1
主要终点
cessation of rectal bleeding

研究概览

简要总结

Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis

详细描述

20 patients with Radiation Proctitis will be randomized to receive either Argon Plasma Coagulation therapy alone or therapy with APC followed by Hemospray administration ;the treatment in each arm is administered during a sigmoidoscopic examination

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •bleeding from radiation proctitis

排除标准

  • •pregnancy bleeding diathesis

研究组 & 干预措施

argon plasma coagulation

Active Comparator

argon plasma coagulation of radiation proctitis

干预措施: Hemospray (Other)

argon plasma coagulator and hemospray

Experimental

treatment of radiation proctitis with argon plasma coagulator followed by application of hemospray

干预措施: Hemospray (Other)

结局指标

主要结局

cessation of rectal bleeding

时间窗: 12 months

treatment of one group of patients with Radiation Proctitis with Argon Plasma Coagulator ( APC) and a second group will be treated with APC and Hemospray

次要结局

  • number of treatments required to achieve cessation of rectal bleeding(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alan Weiss

Principal Investgator

British Columbia Cancer Agency

研究点 (1)

Loading locations...

相似试验

Trial of Argon Plasma Coagulation Versus APC and APC... | 临床试验